Age (years) | Median | 58 | ||
---|---|---|---|---|
Range | 34–78 | |||
Patients | ||||
ECOG performance status | ||||
0 | 15 | 58% | ||
1 | 10 | 38% | ||
2 | 1 | 4% | ||
Primary site: | ||||
Ovarian | 22 | 85% | ||
Fallopian tube | 1 | 4% | ||
Peritoneum | 3 | 11% | ||
Histology | ||||
Serous | 22 | 85% | ||
Endometrioid | 1 | 4% | ||
Endometrioid and clear cell | 1 | 4% | ||
Other | 2 | 7% | ||
Differentiation | ||||
Grade 1 | - | |||
Grade 2 | 1 | 4% | ||
Grade 3 | 24 | 92% | ||
Grade not assigned | 1 | 4% | ||
Tumor expression of mucin 1 by immunohistochemistry | ||||
Positive | 23 | 88% | ||
Negative | 2 | 8% | ||
Not assessed | 1 | 4% |